Content and traffic of taurine in hippocampal reactive astrocytes

Hippocampus

Volumn 21, Issue 2, 2011, Pages 185-197

  Junyent, Fèlix ^a   De Lemos, Luisa ^a   Utrera, Juana ^a   Paco, Sonia ^a   Aguado, Fernando ^a   Camins, Antoni ^a   Pallàs, Mercè ^a   Romero, Rafael ^a   Auladell, Carme ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Astrogliosis; Epilepsy; Kainic acid; Neuroprotection; Taurine transporter

Indexed keywords

AMINO ACID; CARBOXYLYASE; KAINIC ACID; MESSENGER RNA; SULFINIC ACID DERIVATIVE; TAURINE; TAURINE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPILEPSY; GLIA CELL; GLIOSIS; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ASTROCYTES; BASE SEQUENCE; BIOLOGICAL TRANSPORT, ACTIVE; CARBOXY-LYASES; CELLS, CULTURED; CYTOKINES; DNA PRIMERS; GLIOSIS; HIPPOCAMPUS; INFLAMMATION MEDIATORS; KAINIC ACID; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; NERVE TISSUE PROTEINS; RNA, MESSENGER; TAURINE;

EID: 79251542354     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20739     Document Type: Article

References (68)

1. Almarghini K, Remy A, Tappaz M. 1991. Immunocytochemistry of the taurine biosynthesis enzyme, cysteine sulfinate decarboxylase, in the cerebellum: Evidence for a glial localization. Neuroscience 43: 111-119.
2. Baran H. 2006. Alterations of taurine in the brain of chronic kainic acid epilepsy model. Amino Acids 31: 303-307.
3. Barbeau A, Donaldson J. 1974. Zinc, taurine, and epilepsy. Arch Neurol 30: 52-58.
4. Ben-Ari Y, Cossart R. 2000. Kainate, a double agent that generates seizures: Two decades of progress. Trends Neurosci 23: 580-587.
5. Birdsall TC. 1998. Therapeutic applications of taurine. Altern Med Rev 3: 128-136.
6. Blumcke I, Becker A, Klein C, Scheiwe C, Lie A, Beck H, Waha A, Friedl M, Kuhn R, Emson P, Schramamm J, Elger CE, Wlestler OD. 2000. Temporal lobe epilepsy associated up-regulation of metabotropic glutamate receptors: Correlated changes in mGluR1 mRNA and protein expression in experimental animals and human patients. J Neuropathol Exp Neurol 59: 1-10.
7. Cavazos J, Jones S, Cross D. 2004. Sprouting and synaptic reorganization in the subiculum and CA1 region of the hippocampus in acute and chronic models of partial-onset epilepsy. Neuroscience 126: 677-688.
8. Cheema TA, Fisher SK. 2008. Cholesterol regulates volume-sensitive osmolyte efflux from human SH-SY5Y neuroblastoma cells following receptor activation. J Pharmacol Exp Ther 324: 648-657.
9. de la Rosa J, Stipanuk MH. 1985. Evidence for a rate-limiting role of cysteinesulfinate decarboxylase activity in taurine biosynthesis in vivo. Comp Biochem Physiol B 81: 565-571.
10. Dopico JG, Gonzalez-Hernandez T, Perez IM, Garcia IG, Abril AM, Inchausti JO, Rodriguez Diaz M. 2006. Glycine release in the substantia nigra: Interaction with glutamate and GABA. Neuropharmacology 50: 548-557.
11. Dudek F, Hellier J, Williams P, Ferraro D, Staley K. 2002. The course of cellular alterations associated with the development of spontaneous seizures after status epilepticus. Prog Barin Res 135: 53-65.
12. El Idrissi A. 2008. Taurine increases mitochondrial buffering of calcium: Role in neuroprotection. Amino Acids 34: 321-328.
13. El Idrissi A, Messing J, Scalia J, Trenkner E. 2003. Prevention of epileptic seizures by taurine. Adv Exp Med Biol 526: 515-525.
14. El Idrissi A, Trenkner E. 1999. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J Neurosci 19: 9459-9468.
15. Engel JJr, Babb TL, Crandall PH. 1989. Surgical treatment of epilepsy: Opportunities for research into basic mechanisms of human brain function. Acta Neurochir Suppl (Wien) 46: 3-8.
16. Foster DJ, Vitvitsky VM, Banerjee R, Heacock AM, Fisher SK. 2009. Muscarinic receptor regulation of osmosensitive taurine transport in human SH-SY5Y neuroblastoma cells. J Neurochem 108: 437-449.
17. French ED, Vezzani A, Whetsell WOJr, Schwarcz R. 1986. Anti-excitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro. Adv Exp Med Biol 203: 349-362.
18. Fuentes-Santamaria V, Alvarado JC, Herranz AS, Garcia-Atares N, Lopez DE. 2007. Morphologic and neurochemical alterations in the superior colliculus of the genetically epilepsy-prone hamster (GPG/Vall). Epilepsy Res 75: 206-219.
19. Gragera RR, Muniz E, De Esteban G, Alonso MJ, Martinez-Rodriguez R. 1995. Immunohistochemical demonstration of taurine in the rat cerebellar cortex. Evidence for its location within mossy fibers and Golgi axons. J Hirnforsch 36: 269-276.
20. Gupta RC, Win T, Bittner S. 2005. Taurine analogues; a new class of therapeutics: Retrospect and prospects. Curr Med Chem 12: 2021-2039.
21. Hendil KB, Hoffmann EK. 1974. Cell volume regulation in Ehrlich ascites tumor cells. J Cell Physiol 84: 115-125.
22. Huxtable RJ. 1989. Taurine in the central nervous system and the mammalian actions of taurine. Prog Neurobiol 32: 471-533.
23. Huxtable RJ. 1992. Physiological actions of taurine. Physiol Rev 72: 101-163.
24. Izumi K, Butterworth RF, Barbeau A. 1977. Effect of taurine on calcium binding to microsomes isolated from rat cerebral cortex. Life Sci 20: 943-950.
25. Jacobson I, Hamberger A. 1985. Kainic acid-induced changes of extracellular amino acid levels, evoked potentials and EEG activity in the rabbit olfactory bulb. Brain Res 348: 289-296.
26. John GR, Chen L, Rivieccio MA, Melendez-Vasquez CV, Hartley A, Brosnan CF. 2004. Interleukin-1beta induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis. J Neurosci 24: 2837-2845.
27. John GR, Lee SC, Brosnan CF. 2003. Cytokines: Powerful regulators of glial cell activation. Neuroscientist 9: 10-22.
28. Junyent F, Utrera J, Romero R, Pallas M, Camins A, Duque D, Auladell C. 2009. Prevention of epilepsy by taurine treatments in mice experimental model. J Neurosci Res 87: 1500-1508.
29. Kang YS, Ohtsuki S, Takanaga H, Tomi M, Hosoya K, Terasaki T. 2002. Regulation of taurine transport at the blood-brain barrier by tumor necrosis factor-alpha, taurine and hypertonicity. J Neurochem 83: 1188-1195.
30. Kondratyev A, Gale K. 2004. Latency to onset of status epilepticus determines molecular mechanisms of seizure-induced cell death. Brain Res Mol Brain Res 121: 86-94.
31. Kreutzberg GW. 1995. Microglia, the first line of defence in brain pathologies. Arzneimittelforschung 45: 357-360.
32. Kreutzberg GW. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19: 312-318.
33. Law RO. 1998a. Adaptations of cerebral volume-regulatory taurine transport to chronic disturbances of plasma osmolality. Adv Exp Med Biol 442: 237-243.
34. Law RO. 1998b. The role of taurine in the regulation of brain cell volume in chronically hyponatraemic rats. Neurochem Int 33: 467-472.
35. Lee M, Kim S, Choi J, Choi Y, Jeon M, Lee J, Kim I. 2002. Induction of Bis, a Bcl-2-binding protein, in reactive astrocytes of the rat hippocampus following kainic acid-induced seizure. Exp Mol Med 34: 167-171.
36. Lee NY, Kang YS. 2004. The brain-to-blood efflux transport of taurine and changes in the blood-brain barrier transport system by tumor necrosis factor-alpha. Brain Res 1023: 141-147.
37. Lehmann A, Hagberg H, Jacobson I, Hamberger A. 1985. Effects of status epilepticus on extracellular amino acids in the hippocampus. Brain Res 359: 147-151.
38. Leite JP, Garcia-Cairasco N, Cavalheiro EA. 2002. New insights from the use of pilocarpine and kainate models. Epilepsy Res 50: 93-103.
39. Lima L, Matus P, Drujan B. 1989. Spatial distribution of glutamate, taurine and GABA in teleosts and mammals retina: In vivo and in vitro study. Int J Dev Neurosci 7: 295-300.
40. Liu QR, Lopez-Corcuera B, Nelson H, Mandiyan S, Nelson N. 1992. Cloning and expression of a cDNA encoding the transporter of taurine and beta-alanine in mouse brain. Proc Natl Acad Sci USA 89: 12145-12149.
41. Magnusson KR. 1996. Distributions of taurine, glutamate, and glutamate receptors during post-natal development and plasticity in the rat brain. Adv Exp Med Biol 403: 435-444.
42. Muramatsu M, Kakita K, Nakagawa K, Kuriyama K. 1978. A modulating role of taurine on release of acetylcholine and norepinephrine from neuronal tissues. Jpn J Pharmacol 28: 259-268.
43. Mutani R, Durelli L, Mazzarino M, Valentini C, Monaco F, Fumero S, Mondino A. 1977. Longitudinal changes of brain amino acid content occurring before, during and after epileptic activity. Brain Res 122: 513-521.
44. Nagelhus EA, Lehmann A, Ottersen OP. 1993. Neuronal-glial exchange of taurine during hypo-osmotic stress: A combined immunocytochemical and biochemical analysis in rat cerebellar cortex. Neuroscience 54: 615-631.
45. Niquet J, Ben-Ari Y, Represa A. 1994. Glial reaction after seizure induced hippocampal lesion: Immunohistochemical characterization of proliferating glial cells. J Neurocytol 23: 641-656.
46. Ottersen OP. 1988. Quantitative assessment of taurine-like immunoreactivity in different cell types and processes in rat cerebellum: An electronmicroscopic study based on a postembedding immunogold labelling procedure. Anat Embryol (Berl) 178: 407-421.
47. Ottersen OP, Madsen S, Storm-Mathisen J, Somogyi P, Scopsi L, Larsson LI. 1988. Immunocytochemical evidence suggests that taurine is colocalized with GABA in the Purkinje cell terminals, but that the stellate cell terminals predominantly contain GABA: A light- and electronmicroscopic study of the rat cerebellum. Exp Brain Res 72: 407-416.
48. Palmi M, Youmbi GT, Fusi F, Sgaragli GP, Dixon HB, Frosini M, Tipton KF. 1999. Potentiation of mitochondrial Ca2+ sequestration by taurine. Biochem Pharmacol 58: 1123-1131.
49. Pasantes-Morales H, Dominguez L, Campomanes MA, Pacheco P. 1986. Retinal degeneration induced by taurine deficiency in light-deprived cats. Exp Eye Res 43: 55-60.
50. Pasantes-Morales H, Franco R, Torres-Marquez ME, Hernandez-Fonseca K, Ortega A. 2000. Amino acid osmolytes in regulatory volume decrease and isovolumetric regulation in brain cells: Contribution and mechanisms. Cell Physiol Biochem 10: 361-370.
51. Pitkanen A, Nissinen J, Nairismagi J, Lukasiuk K, Grohn O, Miettinen R, Kauppinen R. 2002. Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy. Prog Brain Res 135: 67-83.
52. Pow DV, Sullivan R, Reye P, Hermanussen S. 2002. Localization of taurine transporters, taurine, and (3)H taurine accumulation in the rat retina, pituitary, and brain. Glia 37: 153-168.
53. Represa A, Niquet J, Pollard H, Ben-Ari Y. 1995. Cell death, gliosis, and synaptic remodeling in the hippocampus of epileptic rats. J Neurobiol 26: 413-425.
54. Saransaari P, Oja SS. 2007. Taurine release in mouse brain stem slices under cell-damaging conditions. Amino Acids 32: 439-446.
55. Schurr A, Tseng MT, West CA, Rigor BM. 1987. Taurine improves the recovery of neuronal function following cerebral hypoxia: An in vitro study. Life Sci 40: 2059-2066.
56. Shennan DB. 2008. Swelling-induced taurine transport: Relationship with chloride channels, anion-exchangers and other swelling-activated transport pathways. Cell Physiol Biochem 21: 15-28.
57. Smith KE, Borden LA, Wang CH, Hartig PR, Branchek TA, Weinshank RL. 1992. Cloning and expression of a high affinity taurine transporter from rat brain. Mol Pharmacol 42: 563-569.
58. Solis JM, Herranz AS, Herreras O, Lerma J, Martin del Rio R. 1988. Does taurine act as an osmoregulatory substance in the rat brain? Neurosci Lett 91: 53-58.
59. Tamai I, Senmaru M, Terasaki T, Tsuji A. 1995. Na(+)- and Cl(-)-dependent transport of taurine at the blood-brain barrier. Biochem Pharmacol 50: 1783-1793.
60. Tappaz M, Almarghini K, Do K. 1994. Cysteine sulfinate decarboxylase in brain: Identification, characterization and immunocytochemical location in astrocytes. Adv Exp Med Biol 359: 257-268.
61. Tappaz M, Almarghini K, Legay F, Remy A. 1992. Taurine biosynthesis enzyme cysteine sulfinate decarboxylase (CSD) from brain: The long and tricky trail to identification. Neurochem Res 17: 849-859.
62. Trenkner E. 1990. The role of taurine and glutamate during early postnatal cerebellar development of normal and weaver mutant mice. Adv Exp Med Biol 268: 239-244.
63. Wade JV, Olson JP, Samson FE, Nelson SR, Pazdernik TL. 1988. Apossible role for taurine in osmoregulation within the brain. J Neurochem 51: 740-745.
64. Wilhelmsson ULL, Pekna M, Berthold CH, Blom S, Eliasson C, Renner O, Bushong E, Ellisman M, Morgan TE, Pekny M. 2004. Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration. J Neurosci 24: 2069-2073.
65. Wright CE, Tallan HH, Lin YY, Gaull GE. 1986. Taurine: Biological update. Annu Rev Biochem 55: 427-453.
66. Wu H, Jin Y, Wei J, Jin H, Sha D, Wu JY. 2005. Mode of action of taurine as a neuroprotector. Brain Res 1038: 123-131.
67. Wu JY. 1984. GABA and taurine enzymes in mammalian brain. Curr Top Cell Regul 24: 119-128.
68. Wu JY, Lin CT, Johansen FF, Liu JW. 1994. Taurine neurons in rat hippocampal formation1 are relatively inert to cerebral ischemia. Adv Exp Med Biol 359: 289-298.